Morgan Stanley analyst Drew Ranieri maintains $Intuitive Surgical (ISRG.US)$ with a hold rating, and adjusts the target price from $475 to $522.
According to TipRanks data, the analyst has a success rate of 38.6% and a total average return of -6.1% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Intuitive Surgical (ISRG.US)$'s main analysts recently are as follows:
Intuitive Surgical's recent quarterly earnings surpassed expectations, signaling a robust period driven by the deployment of the Da Vinci 5 system, significant growth in procedure volumes, and effective margin management. Furthermore, company leadership has revised the forecast for procedure volume growth for the fiscal year upwards, accounting for potential variations in bariatric procedures and the current challenges encountered in Asian markets, particularly due to ongoing physician strikes in Korea.
Expectations appear to be set for a significant revenue outperformance for FY25, as reflected in current market sentiments. Following the company's quarterly financial disclosure, it was observed that there's an approximate 3% increase in the anticipated earnings per share for FY25.
The company has reported robust third-quarter results, exceeding expectations in two key areas - the placement of their DV5 systems and the growth in procedures. Following the U.S. approval of the da Vinci 5, the company is experiencing significant growth momentum. The early adoption of the DV5 is surpassing the initial adoption of its predecessor, indicating a promising potential for accelerated growth as we look towards 2025.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
摩根士丹利分析师Drew Ranieri维持$直觉外科公司 (ISRG.US)$持有评级，并将目标价从475美元上调至522美元。
根据TipRanks数据显示，该分析师近一年总胜率为38.6%，总平均回报率为-6.1%。
此外，综合报道，$直觉外科公司 (ISRG.US)$近期主要分析师观点如下：
Intuitive Surgical最近的季度收益超出了预期，这表明在达芬奇5系统的部署、手术量的显著增长和有效的利润管理的推动下，进入了一个强劲的时期。此外，考虑到减肥手术的潜在差异以及亚洲市场当前面临的挑战，特别是韩国持续的医生罢工，公司领导层已经上调了对本财年手术量增长的预测。
正如当前的市场情绪所反映的那样，预计25财年的收入将大幅跑赢大盘。在公司公布季度财务披露后，据观察，25财年的预期每股收益增长了约3％。
该公司公布了强劲的第三季度业绩，在两个关键领域——DV5系统的部署和程序的增长——超出了预期。在美国批准达芬奇5之后，该公司出现了显著的增长势头。DV5的早期采用率超过了其前身的初始采用率，这表明在我们展望2025年时，加速增长的潜力巨大。
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
